All Access Articles |
- IOVANCE BIOTHERAPEUTICS SEES REVENUE SURGE | 2026-07-05 | BIOTECHNOLOGY
- Iovance Biotherapeutics Boosts Revenue Guidance | 2026-07-04 | BIOTECHNOLOGY
- IOVANCE Ends Q1 2026 with $319M Cash, Projects Operations Funded into 2028 | 2026-07-03 | BIOTECHNOLOGY
- IOVANCE BIOTHERAPEUTICS 10-K Report Insights | 2026-02-24 | UNITED STATES
- Iovance Biotherapeutics' amtagvi Receives Health Canada Approval | 2025-08-20 | BIOTECHNOLOGY